Hereditary transthyretin amyloidosis (HTA) Program in Pharmaceutical Benefits Scheme (PBS) 012-24070419

HTA restriction and item codes

Do not share this attachment externally. See Freedom of Information - Information Publication Scheme.

PBS HTA restriction and item codes

PBS Complex Drugs Programs

Table 1: see Table 2 in Processing Complex Authority Required Listings for FAQs about all Complex programs.

Item	Description
1	Is there an age restriction for patients applying for PBS-subsidised treatment of HTA? A: Patients must be aged 18 years or older.
2	Are hospital details required for authority applications for patisiran (Onpattro®)? A: Yes. Hospital details: are required because patisiran is PBS-subsidised under Section 100 arrangements for Highly Specialised Drugs (HSD) Program must be provided for each application for S100 HSD
3	Can increased quantity and/or repeats be authorised for patisiran (Onpattro®)? A: No increase (NO INC) in the PBS-listed maximum quantity and repeats are allowed for this item.